Inari Medical (NASDAQ:NARI) vs. Apyx Medical (NASDAQ:APYX) Head-To-Head Survey

Inari Medical (NASDAQ:NARI) and Apyx Medical (NASDAQ:APYX) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

Risk & Volatility

Inari Medical has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Apyx Medical has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500.

Institutional and Insider Ownership

91.0% of Inari Medical shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 10.6% of Inari Medical shares are held by insiders. Comparatively, 16.8% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Inari Medical and Apyx Medical”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inari Medical	$493.63 million	9.48	-$1.64 million	($1.35)	-59.24
Apyx Medical	$47.29 million	1.33	-$18.71 million	($0.55)	-3.04

Inari Medical has higher revenue and earnings than Apyx Medical. Inari Medical is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Inari Medical and Apyx Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inari Medical	0	12	2	0	2.14
Apyx Medical	0	2	0	1	2.67

Inari Medical presently has a consensus target price of $69.22, suggesting a potential downside of 13.44%. Given Inari Medical’s higher probable upside, equities analysts plainly believe Inari Medical is more favorable than Apyx Medical.

Profitability

This table compares Inari Medical and Apyx Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inari Medical	-13.68%	-10.09%	-6.60%
Apyx Medical	-58.59%	-137.98%	-36.74%

Summary

Inari Medical beats Apyx Medical on 9 of the 15 factors compared between the two stocks.

About Inari Medical

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.